Evaluation of prospective urinary protein biomarkes in the early detection of soft tissue sarcoma/ osteosarcoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021209

Enrollment

Registered

2020-04-20

Start date

2019-09-26

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C41 C49

Interventions

Group 1: The aim of the study is to examine urine samples of patients diagnosed with musculoskeletal tumors (osteosarcoma, Ewingsarcoma, soft tissue sarcoma). The urine samples will be analysed using

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with suspected malignant musculoskeletal tumor.

Exclusion criteria

Exclusion criteria: Pregnancy. Nursing period. Benign musculoskeletal tumor.

Design outcomes

Primary

Measure	Time frame
Primary endpoint of the study is to characterize urinary proteom patterns which are associated with different entities of musculoskeletal tumors at the time of primary diagnosis.	—

Secondary

Measure	Time frame
No secondary endpoint. This study will be used as a pretrial to evaluate the necessary sample size.	—

Countries

Germany

Contacts

Public ContactMohamed Omar

Medizinische Hochschule Hannover

omar.mohamed@mh-hannover.de01631355032

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026